Cystatin C, creatinine, estimated glomerular filtration, and long-term mortality in stroke patients

References

• Bhatnagar P, Scarborough P, Smeeton NC, Allender S. The incidence of all stroke and stroke subtype in the United Kingdom, 1985 to 2008: a systematic review. BMC Public Health. 2010;10:539
   PubMed Web of Science ®Google Scholar
• Cooper R, Cutler J, Desvigne-Nickens P, et al. Trends and disparities in coronary heart diseases, stroke, and other cardiovascular disease in the United States: findings of the National Conference on cardiovascular Disease Prevention. Circulation. 2000;102(25):3137–3147
   PubMed Web of Science ®Google Scholar
• Manjunath G, Tighiouart H, Coresh J, et al. Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int. 2003;63(3):1121–1129
   Web of Science ®Google Scholar
• Garg AX, Clark WF, Haynes RB, et al. Moderate renal insufficiency and the risk of cardiovascular mortality: results from the NHANES I. Kidney Int. 2002;61(4):1486–1494
   PubMed Web of Science ®Google Scholar
• Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296–1305
   PubMed Web of Science ®Google Scholar
• Kawagishi T, Nishizawa Y, Konishi T, et al. High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia. Kidney Int. 1995;48(3):820–826
   PubMedGoogle Scholar
• Hojs R. Carotid intima-media thickness and plaques in hemodialysis patients. Artif Organs. 2000;24(9):691695
   Google Scholar
• Seliger SL, Gillen DL, Longstreth WT Jr, Kestenbaum B, Stehman-Breen CO. Elevated risk of stroke among patients with end-stage renal disease. Kidney Int. 2003;64(2):603–609
   PubMed Web of Science ®Google Scholar
• Tsagalis G, Akrivos T, Alevizaki M, et al. Renal dysfunction in acute stroke: an independent predictor of long-term all combined vascular events and overall mortality. Nephrol Dial Transplant. 2009;24(1):194–200
   PubMed Web of Science ®Google Scholar
• Yahalom G, Schwartz R, Schwammenthal Y, et al. Chronic kidney disease and clinical outcome in patients with acute stroke. Stroke. 2009;40(4):1296–1303
   PubMed Web of Science ®Google Scholar
• Hojs Fabjan T, Hojs R, Tetickovic E, Pecovnik Balon B. Ischemic stroke — impact of renal dysfunction on in-hospital mortality. Eur J Neurol. 2007;14(12):1351–1356
   Web of Science ®Google Scholar
• MacWalter RS, Wong SYS, Wong KYK. Does renal dysfunction predict mortality after acute stroke? A 7-year follow-up study. Stroke. 2002;33(6):130–135
   Google Scholar
• Ovbiagele B. Chronic kidney disease and risk of death during hospitalization for stroke. J Neurol Sci. 2011;301(1–2):46–50
   Google Scholar
• Lee M, Saver JL, Chang KH, Liao HW, Chang SC, Ovbigale B. Low glomerular filtration rate and risk of stroke: meta-analysis. BMJ. 2010;341:c4249
   PubMed Web of Science ®Google Scholar
• National Kidney Fundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1–266
   Google Scholar
• Froissart M, Rossert J, Jacquot C, et al. Predictive performance of the modification of diet in renal disease and Cockcroft–Gault equations for estimating renal function. J Am Soc Nephrol. 2005;16(3):763–773
   PubMed Web of Science ®Google Scholar
• Miller WG. Reporting estimated GFR: a laboratory perspective. Am J Kidney Dis. 2008;52(4):645–648
   PubMed Web of Science ®Google Scholar
• Hojs R, Bevc S, Ekart R, Gorenjak M, Puklavec L. Kidney function estimating equations in patients with chronic kidney disease. Int J Clin Pract. 2011;65(4):458–464
   Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). Ann Intern Med. 2009;150(9):604–612
   PubMed Web of Science ®Google Scholar
• Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis. 2002;40(2):221–226
   PubMed Web of Science ®Google Scholar
• Randers E, Erlandsen EJ. Serum cystatin C as an endogenous marker of renal function: a review. Clin Chem Lab Med. 1999;37(4):389–395
   PubMed Web of Science ®Google Scholar
• Coll E, Botey A, Alvarez L, et al. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis. 2000;36(1):29–34
   PubMed Web of Science ®Google Scholar
• Finney H, Williams AH, Price CP. Serum cystatin C in patients with myeloma. Clin Chim Acta. 2001;309(1):1–6
   PubMed Web of Science ®Google Scholar
• Fricker M, Wiesli P, Brundle M, et al. Impact of thyroid dysfunction on serum cystatin C. Kidney Int. 2003;63(5):1944–1947
   PubMed Web of Science ®Google Scholar
• Risch L, Herklotz R, Blumberg A, Huber AR. Effects of glucocorticoid immunosuppresion on serum cystatin C concentrations in renal transplant patients. Clin Chem. 2001;47(11):2055–2059
   PubMed Web of Science ®Google Scholar
• Shlipak MG, Sarnak MJ, Katz R, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med. 2005;352(20):2049–2060
   PubMed Web of Science ®Google Scholar
• de Boer IH, Katz R, Cao JJ, et al. Cystatin C, albuminuria, and mortality among older adults with diabetes mellitus. Diabetes Care. 2009;32(10):1833–1838
   Google Scholar
• Stevens LA, Coresh J, Schmid CH, et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3418 individuals with CKD. Am J Kidney Dis. 2008;51(3):395–406
   PubMed Web of Science ®Google Scholar
• Ni L, Lü J, Hou LB, et al. Cystatin C, associated with hemorrhagic and ischemic stroke, is a strong predictor of the risk of cardiovascular events and death in Chinese. Stroke. 2007;38(12):3287–3288
   Google Scholar
• Thorvaldsen P, Asplund K, Kuulasmaa K, et al. Stroke incidence, case fatality, and mortality in the WHO MONICA project. World Health Organisation Monitoring Trends and Determinants in Cardiovascular Disease. Stroke. 1995;26(3):361–367
   Google Scholar
• Muir KW, Weir CJ, Murray GD, Povey C, Lees KR. Comparison of neurological scales and scoring systems for acute stroke prognosis. Stroke. 1996;27(10):1817–1820
   PubMed Web of Science ®Google Scholar
• Mazzachi BC, Peake MJ, Ehrhardt V. Reference range and method comparison studies for enzymatic and Jaffé creatinine assay in plasma and serum and early morning urine. Clin Lab. 2000;46(1–2):53–55
   Google Scholar
• Rydén L, Standl E, Bartnik M, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J. 2007;28(1):88–136
   PubMed Web of Science ®Google Scholar
• Mancia G, De Backer G, Dominiczak A, et al. Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25(6):1105–1187
   PubMed Web of Science ®Google Scholar
• Bevc S, Hojs R, Ekart R, Gorenjak M, Puklavec L. Simple cystatin C formula compared to sophisticated CKD-EPI formulas for estimation of glomerular filtration rate in the elderly. Ther Apher Dial. 2011;15(3):261–268
   Google Scholar
• Bevc S, Hojs R, Ekart R, Završnik M, Gorenjak M, Puklavec L. Simple cystatin C formula for estimation of glomerular filtration rate in overweight patients with diabetes mellitus type 2 and chronic kidney disease. Exp Diabetes Res. 2012 . [Epub ahead of print]. doi:10.1155/2012/179849
   Google Scholar
• Matsushita K, Mahmodi BK, Woodward M, et al. Comparison of risk prediction using the CKD-EPI equation and the MDRD Study equation for estimated glomerular filtration risk. JAMA. 2012;307(18):1941–1951
   PubMed Web of Science ®Google Scholar
• Astor BC, Levey AS, Stevens LA, Van Lente F, Selvin E, Coresh J. Method of glomerular filtration rate estimation affects prediction of mortality risk. J Am Soc Nephrol. 2009;20(10):2214–2222
   PubMed Web of Science ®Google Scholar
• Sarnak MJ, Katz R, Stehman-Breen CO, et al. Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med. 2005;142(7):497–505
   Google Scholar
• O'Riordan SE, Webb MC, Stowe HJ, et al. Cystatin C improves the detection of mild renal dysfunction in older patients. Ann Clin Biochem. 2003;40(Pt 6):648–655
   Google Scholar
• Ix JH, Shlipak MG, Chertow GM, Whooley MA. Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study. Circulation. 2007;115(2):173–179
   PubMed Web of Science ®Google Scholar
• Naruse H, Ishii J, Kawai T, et al. Cystatin C in acute heart failure without advanced renal impairment. Am J Med. 2009;122(6):566–573
   PubMed Web of Science ®Google Scholar
• Urbonaviciene G, Shi GP, Urbonavicius S, Henneberg EW, Lindholt JS. Higher cystatin C level predicts long-term mortality in patients with peripheral arterial disease. Atherosclerosis. 2011;216(2):440–445
   PubMed Web of Science ®Google Scholar
• Keller T, Messow CM, Lubos E, et al. Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene study. Eur Heart J. 2009;30(3):314–320
   PubMed Web of Science ®Google Scholar
• Wu CK, Lin JW, Caffrey JL, Chang MH, Hwang JJ, Lin YS. Cystatin C and long-term mortality among subjects with normal creatinine-based estimated glomerular filtration rates: NHANES III (Third National Health and Nutrition Examination Survey). J Am Coll Cardiol. 2010;56(23):1930–1936
   PubMed Web of Science ®Google Scholar
• Astor BC, Shafi T, Hoogeveen RC, et al. Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population. Am J Kidney Dis. 2012;59(5):653–662
   PubMed Web of Science ®Google Scholar
• Astor BC, Shaikh S, Chaundry M. Association of endogenous markers of kidney function with outcomes: more and less than glomerular filtration rate. Curr Opin Nephrol Hypertens. 2013;22(3):331–335
   Google Scholar
• Seliger SL, Longstreth WT Jr, Katz R, et al. Cystatin C and subclinical brain infarction. J Am Soc Nephrol. 2005;16(12):3721–3727
   PubMed Web of Science ®Google Scholar
• Xiao D, Liu H, Zhang H, Luo Y. Impact of cystatin C levels on infarct size and hemorrhage volume in acute cerebral stroke. J Neurol. 2012;259(10):2053–2059
   PubMed Web of Science ®Google Scholar